GREAT INTEREST IN THE PHASE 2 TRIAL FOR PATIENTS WITH AUD
At the 36th ECNP Congress in Barcelona Spain October 6-10, 2023, Professor Bo Söderpalm, Addiction Biology Unit, Institute of Neuroscience and Physiology, University of Gothenburg, Sweden, [...]